Arena Pharmaceuticals Inc ARNA
We take great care to ensure that the data presented and summarized in this overview for ARENA PHARMACEUTICALS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ARNA
Top Purchases
Top Sells
About ARNA
Insider Transactions at ARNA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2022
|
Robert Lisicki EVP, Chief Commercial Officer |
SELL
Other acquisition or disposition
|
Direct |
37,563
-49.61%
|
-
|
|
Mar 11
2022
|
Vincent Aurentz Executive VP and CBO |
SELL
Other acquisition or disposition
|
Direct |
55,964
-57.81%
|
-
|
|
Mar 11
2022
|
Joan Schmidt EVP, General Counsel & Sec |
SELL
Other acquisition or disposition
|
Direct |
36,287
-48.73%
|
-
|
|
Mar 11
2022
|
Amit Munshi President and CEO |
SELL
Other acquisition or disposition
|
Direct |
114,897
-41.78%
|
-
|
|
Mar 11
2022
|
Laurie Stelzer EVP & Chief Financial Officer |
SELL
Other acquisition or disposition
|
Direct |
37,208
-49.37%
|
-
|
|
Mar 11
2022
|
Douglas J. Manion EVP Research & Development |
SELL
Other acquisition or disposition
|
Direct |
36,462
-70.57%
|
-
|
|
Mar 11
2022
|
Nawal Ouzren Director |
SELL
Other acquisition or disposition
|
Direct |
4,555
-59.77%
|
-
|
|
Mar 11
2022
|
Jayson Donald Alexander Dallas Director |
SELL
Other acquisition or disposition
|
Direct |
7,152
-78.56%
|
-
|
|
Mar 11
2022
|
Steven J Schoch Director |
SELL
Other acquisition or disposition
|
Direct |
4,600
-100.0%
|
-
|
|
Mar 11
2022
|
Garry Arthur Neil Director |
SELL
Other acquisition or disposition
|
Direct |
11,217
-86.33%
|
-
|
|
Mar 11
2022
|
Jennifer Jarrett Director |
SELL
Other acquisition or disposition
|
Direct |
11,217
-86.33%
|
-
|
|
Mar 11
2022
|
Katharine Knobil Director |
SELL
Other acquisition or disposition
|
Direct |
6,821
-71.54%
|
-
|
|
Mar 11
2022
|
Kieran Gallahue Director |
SELL
Other acquisition or disposition
|
Direct |
9,283
-56.01%
|
-
|
|
Mar 11
2022
|
Kieran Gallahue Director |
SELL
Other acquisition or disposition
|
Indirect |
3,628
-100.0%
|
-
|
|
Mar 11
2022
|
Oliver Fetzer Director |
SELL
Other acquisition or disposition
|
Direct |
9,692
-57.87%
|
-
|
|
Mar 11
2022
|
Tina Susan Nova Director |
SELL
Other acquisition or disposition
|
Direct |
20,843
-92.64%
|
-
|
|
Mar 08
2022
|
Amit Munshi President and CEO |
SELL
Bona fide gift
|
Direct |
10,500
-8.37%
|
$1,029,000
$98.51 P/Share
|
|
Jan 03
2022
|
Vincent Aurentz Executive VP and CBO |
BUY
Grant, award, or other acquisition
|
Direct |
21,462
+28.02%
|
-
|
|
Jan 03
2022
|
Robert Lisicki EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,462
+36.36%
|
-
|
|
Jan 03
2022
|
Laurie Stelzer EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,462
+37.11%
|
-
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders